Amesite Operating Co
$ 1.76
-2.22%
16 Apr - close price
- Market Cap 8,230,900 USD
- Current Price $ 1.76
- High / Low $ 1.82 / 1.73
- Stock P/E N/A
- Book Value 0.33
- EPS -0.60
- Next Earning Report 2026-05-21
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.89 %
- ROE -2.15 %
- 52 Week High 4.78
- 52 Week Low 1.57
About
Amesite Inc., an artificial intelligence-powered platform and course designer, offers products and services online in the United States. The company is headquartered in Detroit, Michigan.
Analyst Target Price
$7.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-24 | 2025-09-29 | 2025-05-08 | 2025-02-12 | 2024-11-11 | 2024-08-28 | 2024-05-10 | 2024-02-14 | 2023-11-13 | 2023-09-29 | 2023-05-15 | 2023-02-10 |
| Reported EPS | -0.14 | -0.2 | -0.1636 | -0.4017 | -0.3354 | -0.4645 | -0.5608 | -0.3562 | -0.3503 | -0.3731 | -0.11 | -0.72 |
| Estimated EPS | 0 | 0 | None | None | None | None | None | None | None | None | -0.08 | -0.48 |
| Surprise | -0.14 | -0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.03 | -0.24 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | -37.5% | -50% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-21 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AMST
2026-04-01 22:40:59
Amesite Inc. director Barbie Brewer was granted 7,541 restricted stock units (RSUs) as deferred stock units, which serve as compensation in lieu of cash fees for her board service. The number of units was calculated based on the closing share price on the last day of the quarter. Following this grant, Ms. Brewer directly holds 30,322 shares or equivalents, with the RSUs representing a contingent right to receive common stock or its cash equivalent upon the cessation of her board service or a change in control.
2026-04-01 22:40:59
Amesite Inc. director J. Michael Losh has been granted 7,880 restricted stock units (RSUs) as deferred compensation for board service, credited to his irrevocable annuity trust. These units are tied to the closing share price on the last day of the quarter and represent a contingent right to receive Amesite common stock or its cash equivalent. The trust now holds a total of 90,363 deferred/restricted stock units associated with Mr. Losh.
2026-04-01 22:40:59
Amesite Inc. director Gilbert S. Omenn, through his revocable trust, received 6,522 restricted stock units (RSUs) on March 31, 2026. These RSUs were awarded in lieu of cash director fees, with each unit representing one share of Amesite common stock or its cash equivalent. This grant increases the trust's reported indirect holdings to 74,783 shares, and the deferred stock units will be delivered upon Omenn's departure from the board or an earlier change in control.
2026-04-01 19:40:59
Amesite Inc. has announced a new Electronic Transactions Trading Partner Agreement with a leading homecare technology platform, enabling secure and compliant Electronic Visit Verification (EVV) integration for its AI-native NurseMagic™ EMR system. This partnership allows NurseMagic™ to seamlessly connect with existing EVV systems, streamlining workflows and ensuring compliance with CMS and 21st Century Cures Act standards for non-acute care providers. Dr. Ann Marie Sastry, CEO of Amesite, highlighted that this makes NurseMagic™ the first AI-first EMR solution for non-acute care, validating their infrastructure-first approach in a significant market.
2026-03-27 07:10:36
Amesite Inc. has signed an Electronic Transactions Trading Partner Agreement with a major homecare technology platform, enabling HIPAA-compliant exchange of EVV transactions. This agreement permits NurseMagic™, Amesite's AI-native platform, to securely connect and integrate AI-powered workflows into existing homecare operations, streamlining compliance and enhancing efficiency. The company highlights this as a significant step in delivering an AI-first EMR solution for the non-acute care market.
2026-03-26 17:08:45
Amesite Inc. has signed a trading partner agreement with a major homecare technology platform to enable secure, HIPAA-compliant electronic visit verification (EVV) transactions. This integration connects Amesite's AI-native NurseMagic™ EMR platform with existing homecare compliance infrastructure, allowing providers to leverage AI-powered workflows without changing their EVV processes. The CEO highlights this as a significant step in delivering an AI-first EMR solution to the non-acute care market.
